Live Breaking News & Updates on Early Recovery Post Myocardial Infarction

Interim Analysis of Recardio s Phase II Clinical Trial Published in European Heart Journal
Recardio Inc., a life science company developing regenerative therapies for cardiovascular diseases, announced that its positive results of the interim analysis of Recardio s Phase II clinical trial in AMI were published in the latest release of the European Heart Journal. The current version of the journal relates to the presentation during the 2020 Congress of the European Society of Cardiology.
News provided by
Share this article
Share this article
SAN FRANCISCO, Dec. 17, 2020 /PRNewswire/  Entitled Randomized, Double Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction: rationale, design and first interim analysis , the publication provides a first insight into patient outcomes of the trial that is currently ongoing in multiple centers. Patients included in this trial experie ....

United States , San Francisco , Recardio Inc , Double Blind , Efficacy Study , Early Recovery Post Myocardial Infarction , Myocardial Infarction , European Heart Journal , ஒன்றுபட்டது மாநிலங்களில் , சான் பிரான்சிஸ்கோ , இரட்டை குருட்டு , ஐரோப்பிய இதயம் இதழ் ,